Coxsackievirus A6: A new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide

Expert Review of Anti-Infective Therapy

Volumn 13, Issue 9, 2015, Pages 1061-1071

  Bian, Lianlian ^a   Wang, Yiping ^a   Yao, Xin ^a   Mao, Qunying ^a   Xu, Miao ^a   Liang, Zhenglun ^a  

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

coxsackievirus A16; coxsackievirus A6; enterovirus 71; hand, foot and mouth disease; vaccine

Indexed keywords

PROTEIN VP1;

ASIA; CLINICAL FEATURE; COXSACKIEVIRUS A6; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENTEROVIRUS; EPIDEMIC; EUROPE; GENE SEQUENCE; HAND FOOT AND MOUTH DISEASE; HUMAN; LABORATORY DIAGNOSIS; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; NORTH AMERICA; ONSET AGE; PHYLOGENETIC TREE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VIRUS CULTURE; VIRUS IDENTIFICATION; VIRUS STRAIN; WINTER; COXSACKIEVIRUS INFECTIONS; DISEASE OUTBREAKS; HAND, FOOT AND MOUTH DISEASE; HEALTH; ISOLATION AND PURIFICATION; TRENDS;

COXSACKIEVIRUS INFECTIONS; DISEASE OUTBREAKS; ENTEROVIRUS; GLOBAL HEALTH; HAND, FOOT AND MOUTH DISEASE; HUMANS;

EID: 84939209670     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2015.1058156     Document Type: Review

References (72)

1. Lu QB, Zhang XA, Wo Y, et al. Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011. PLoS One 2012; 7 (12): e52073
2. Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010; 10 (11): 778-90
3. McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002; 26 (1): 91-107
4. National outline of epidemic situation of statutory infectious diseases. Available from: www.nhfpc.gov.cn/zhuzhan/yqxx/lists.shtml
5. Mirand A, Henquell C, Archimbaud C, et al. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect 2012; 18 (5): E110-18
6. Mao Q, Wang Y, Yao X, et al. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother 2014; 10 (2): 360-7
7. Yip CC, Lau SK, Woo PC, et al. Human enterovirus 71 epidemics: whats next? Emerg Health Threats J 2013; 6: 19780
8. Cabrerizo M, Tarragó D, Muñoz-Almagro C, et al. Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain. Clin Microbiol Infect 2014; 20 (3): O150-6
9. Osterback R, Vuorinen T, Linna M, et al. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis 2009; 15 (9): 1485-8. 2009
10. Bracho MA, González-Candelas F, Valero A, et al. Enterovirus co-infections and onychomadesis after hand, foot, and mouth disease, Spain, 2008. Emerg Infect Dis 2011; 17 (12): 2223-31
11. Wu Y, Yeo A, Phoon MC, et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis 2010; 14 (12): e1076-81
12. Chen YJ, Chang SC, Tsao KC, et al. Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities. PLoS One 2012; 7 (12): e52432
13. Fujimoto T, Iizuka S, Enomoto M, et al. Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis 2012; 18 (2): 337-9
14. Puenpa J, Chieochansin T, Linsuwanon P. Hand, foot, and mouth disease caused by coxsackievirus A6,Thailand,2012. Emerg Infect Dis 2013; 19 (4): 641-3
15. Han JF, Xu S, Zhang Y, et al. Hand, foot, and mouth disease outbreak caused by coxsackievirus A6, China, 2013. J Infect 2014; 69 (3): 303-5
16. Lu J, Zeng H, Zheng H, et al. Hand, foot and mouth disease in Guangdong, China, in 2013: new trends in the continuing epidemic. Clin Microbiol Infect 2014; 20 (7): O442-5
17. Hongyan G, Chengjie M, Qiaozhi Y, et al. Hand, foot and mouth disease caused bycoxsackievirusA6,Beijing,2013. Pediatr Infect Dis J 2014; 33 (12): 1302-3
18. He YQ, Chen L, Xu WB, et al. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-Associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China. J Clin Microbiol 2013; 51 (11): 3560-6
19. Li JL, Yuan J, Yang F, et al. Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent. J Infect 2014; 69 (3): 299-303
20. Di B, Zhang Y, Xie H, et al. Circulation of Coxsackievirus A6 in hand-foot-mouth disease in Guangzhou, 2010-2012. Virol J 2014; 11: 157
21. Wei C, Weng YW, He WX, et al. Molecular epidemiology of HFMD-Associated pathogen Coxsackievirus A6 in Fujian Province, 2011-2013. Chinese J Virol 2014; 30 (6): 624-9
22. Centers for Disease Control and Prevention (CDC). Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6-Alabama, Connecticut, California, and Nevada, November 2011-February 2012. MMWR Morb Mortal Wkly Rep 2012; 61 (12): 213-14
23. Fonseca MC, Sarmiento L, Resik S, et al. Coxsackievirus A6 and enterovirus 71 causing hand, foot and mouth disease in Cuba, 2011-2013. Arch Virol 2014; 159 (9): 2451-5
24. Flett K, Youngster I, Huang J, et al. Hand, foot, and mouth disease caused by coxsackievirus A6. Emerg Infect Dis 2012; 18 (10): 1702-4
25. Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 2014; 370 (9): 818-28
26. Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-Adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013; 381 (9882): 2024-32
27. Li R, Liu L, Mo Z, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med 2014; 370 (9): 829-37
28. Chen YJ, Meng FY, Mao Q, et al. Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial. Hum Vaccin Immunother 2014; 10 (5): 1366-72
29. Shenyu W, Jingxin L, Zhenglun L, et al. A booster dose of an inactivated enterovirus 71 vaccine in Chinese young children: a randomized, double-blind, placebo-controlled clinical trial. J Infect Dis 2014; 210 (7): 1073-82
30. Li YP, Liang ZL, Xia JL, et al. Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, randomized, double-blind, placebo-controlled trial. J Infect Dis 2014; 209 (1): 46-55
31. Liu CC, Chow YH, Chong P, et al. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases. Vaccine 2014; 32 (47): 6177-82
32. Cai Y, Ku Z, Liu Q, et al. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses. Vaccine 2014; 32 (21): 2406-12
33. Klein MH. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines. Expert Rev Vaccines 2014. [Epub ahead of print]
34. Ku Z, Liu Q, Ye X, et al. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine 2014; 32 (34): 4296-303
35. Sun S, Jiang L, Liang Z, et al. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice. Hum Vaccin Immunother 2014; 10 (10): 2885-95
36. Chumakov M, Voroshilova M, Shindarov L, et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol 1979; 60 (3-4): 329-40
37. Ho M. Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect 2000; 33 (4): 205-16
38. Vallet S, Legrand Quillien MC, Dailland T, et al. Fatal case of enterovirus 71 infection, France, 2007. Emerg Infect Dis 2009; 15 (11): 1837-40
39. Rabenau HF, Richter M, Doerr HW. Hand, foot and mouth disease: seroprevalence of coxsackievirus A16 and enterovirus 71 in Germany. Med Microbiol Immunol 2010; 199 (1): 45-51
40. Blomqvist S, Paananen A, Savolainen-Kopra C, et al. Eight years of experience with molecular identification of human enteroviruses. J Clin Microbiol 2008; 46 (7): 2410-13
41. Blomqvist S, Klemola P, Kaijalainen S, et al. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol 2010; 48 (1): 49-54
42. Montes M, Artieda J, Piñeiro LD, et al. Hand, foot, and mouth disease outbreak and coxsackievirus A6, northern Spain, 2011. Emerg Infect Dis 2013; 19: 4
43. Sinclair C, Gaunt E, Simmonds P, et al. Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro Surveill 2014; 19 (12): 20745
44. Lo SH, Huang YC, Huang CG, et al. Clinical and epidemiologic features of Coxsackie virus A6 infection in children in northern Taiwan between 2004 and 2009. J Microbiol Immunol Infect 2011; 44 (4): 252-7
45. Sano T, Saito T, Kondo M, et al. Enterovirus detection status of patients with herpangina and hand, foot and mouth disease in epidemic season 2007, Kanagawa Prefecture, Japan. Jpn J Infect Dis 2008; 61 (2): 162-3
46. Ang LW, Koh BK, Chan KP, et al. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore 2009; 38 (2): 106-12
47. Wei SH, Huang YP, Liu MC, et al. An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect Dis 2011; 11: 346
48. Miyamoto A, Hirata R, Ishimoto K, et al. An outbreak of hand-foot-And-mouth disease mimicking chickenpox, with a frequent association of onychomadesis in Japan in 2009: a new phenotype caused by coxsackievirus A6. Eur J Dermatol 2014; 24 (1): 103-4
49. Akiyoshi K, Suga T, Mori A. Enteroviruses in patients experiencing multiple episodes of hand, foot, and mouth disease in the same season in Kobe, Japan,2011. Jpn J Infect Dis 2012; 65 (5): 459-61
50. Linsuwanon P, Puenpa J, Huang SW, et al. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci 2014; 21: 16
51. Gopalkrishna V, Patil PR, Patil GP, et al. Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India. J Med Microbio 2012; 61 (Pt 3): 420-5
52. Xu M, Su L, Cao L, et al. Enterovirus genotypes causing hand foot and mouth disease in Shanghai, China: a molecular epidemiological analysis. BMC Infect Dis 2013; 13: 489
53. Tan X, Li L, Zhang B, et al. Molecular epidemiology of coxsackievirus A6 associated with outbreaks of hand, foot, and mouth disease in Tianjin, China, in 2013. Arch Virol 2015; 160 (4): 1097-104
54. Dalldorf G. The coxsackievirus group. Ann N Y Acad Sci 1953; 56 (3): 583-6
55. Chen P, Tao ZX, Wang HY, et al. Identification and genetic characterization of coxsackieviruses A2, 6, 8 and 12 isolated in Shandong Province. Chin J Virol 2012; 28 (5): 522-6
56. Rao CD, Yergolkar P, Shankarappa KS, et al. Antigenic diversity of enteroviruses associated with nonpolio acute flaccid paralysis, India, 2007-2009. Emerg Infect Dis 2012; 18 (11): 1833-40
57. Gaunt E, Harvala H, Osterback R, et al. Genetic characterisation of Coxsackievirus A6 variants associated with atypical hand, foot and mouth disease; a potential role of recombination in emergence and pathogenicity. J Gen Virol 2015. [Epub ahead of print]
58. Hubiche T, Schuffenecker I, Boralevi F, et al. Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema. Pediatr Infect Dis J 2014; 33 (4): e92-8
59. Logotheti M, Pogka V, Horefti E, et al. Laboratory investigation and phylogenetic analysis of enteroviruses involved in an aseptic meningitis outbreak in Greece during the summer of 2007. J Clin Virol 2009; 46 (3): 270-4
60. Richter J, Koptides D, Tryfonos C, et al. Molecular typing of enteroviruses associated with viral meningitis in Cyprus, 2000-2002. J Med Microbiol 2006; 55 (Pt 8): 1035-41
61. Lee MK, Chan PK, Ho II, et al. Enterovirus infection among patients admitted to hospital in Hong Kong in 2010: epidemiology, clinical characteristics, and importance of molecular diagnosis. J Med Virol 2013; 85 (10): 1811-17
62. Kaminska K, Martinetti G, Lucchini R, et al. Coxsackievirus A6 and hand, foot and mouth disease: three case reports of familial child-to-immunocompetent adult transmission and a literature review. Case Rep Dermatol 2013; 5 (2): 203-9
63. Ben-Chetrit E, Wiener-Well Y, Shulman LM, et al. CoxsackievirusA6-related hand foot and mouth disease: skin manifestations in a cluster of adult patients. J Clin Virol 2014; 59 (3): 201-3
64. Clementz GC, Mancini AJ. Nail matrix arrest following hand-foot-mouth disease: a report of five children. Pediatr Dermatol 2000; 17 (1): 7-11
65. Bernier V, Labrèze C, Bury F, et al. Nail matrix arrest in the course of hand, foot and mouth disease. Eur J Pediatr 2001; 160 (11): 649-51
66. Kim EJ, Park HS, Yoon HS, et al. Four cases of onychomadesis after hand-foot-mouth disease. Ann Dermatol 2014; 26 (6): 777-8
67. Lin TL, Li YS, Huang CW, et al. Rapid and highly sensitive coxsackievirus a indirect immunofluorescence assay typing kit for enterovirus serotyping. J Clin Microbiol 2008; 46 (2): 785-8
68. She RC, Preobrazhensky SN, Taggart EW, et al. Flow cytometric detection and serotyping of enterovirus for the clinical laboratory. J Virol Methods 2009; 162 (1-2): 245-50
69. Sugawara T, Fujimoto T, Ohkusa Y, et al. The possibility of outbreak control by real-time surveillance with PCR method performed immediately-A case study of hand foot and mouth disease outbreak in a day care facility for children. Kansenshogaku Zasshi 2012; 86 (4): 405-10
70. Zhang L, Wang X, Zhang Y, et al. Rapid and sensitive identification of RNA from the emerging pathogen, coxsackievirus A6. Virol J 2012; 9: 298
71. Hu XM, Zhang Y, Xu BL, et al. Development of a GeXP based multiplex RT-PCR assay for simultaneous differentiation of nine human hand, foot and mouth disease pathogens. Chin J Virol 2011; 27 (4): 331-6
72. Liu Q, Tong X, Huang Z, et al. Towards broadly protective polyvalent vaccines against hand, foot and mouth disease. Microbes Infect 2015; 17 (2): 155-62